The role of immunosuppressive therapy in post-COVID-19 interstitial lung disease

Sadeleştirilmiş öğe sayfası
dc.contributor.authorGul, Sule
dc.contributor.authorDemirkol, Baris
dc.contributor.authorEren, Ramazan
dc.contributor.authorBaydili, Kursad Nuri
dc.contributor.authorElkhatroushi, Burcu Babaoglu
dc.contributor.authorUlusan, Serife Nur
dc.contributor.authorIlhan, Umut
dc.contributor.authorCortuk, Mustafa
dc.contributor.authorCetinkaya, Erdogan
dc.date.accessioned2025-10-16T15:14:38Z
dc.date.issued2023
dc.description.abstractAnnual Congress of the European-Respiratory-Society (ERS), Milan, IA, SEP 09-13, 2023
dc.identifier.doi10.1183/13993003.congress-2023.PA4591
dc.identifier.otherWOS:001109120508065
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/6230
dc.publisherEUROPEAN RESPIRATORY SOC JOURNALS LTD
dc.sourceEUROPEAN RESPIRATORY JOURNAL
dc.titleThe role of immunosuppressive therapy in post-COVID-19 interstitial lung disease
dc.typeMeeting Abstract

Dosyalar

Koleksiyonlar

WOS